Cardiologist, CMO and Co-Founder
Spiorad Medical Limited
Spiorad Medical is developing a specialized closure device for large French 12F-24F femoral artery access sites, aimed at enhancing procedural efficiency for interventionalists. This technology addresses the challenge of achieving secure closure while optimizing patient recovery outcomes.
- Healthcare Technology
- Medical Devices
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Interventionalists face challenges in achieving secure and efficient closure of large French 12F-24F femoral artery access sites after procedures. Current closure methods may not be optimal, potentially leading to complications and prolonged patient recovery times.
Solution
Spiorad Medical is developing a specialized closure device designed to simplify and improve the closure of large French 12F-24F femoral artery access sites. The device aims to provide interventionalists with an easier-to-use solution that promotes better clinical outcomes and faster patient recovery. By focusing on procedural efficiency and secure closure, Spiorad Medical seeks to address the unmet needs in large-bore femoral artery access site management. The technology is being developed with the goal of optimizing both the interventionalist's experience and the patient's post-procedure recovery.
Target Audience
The primary target audience includes interventional cardiologists and vascular surgeons who perform procedures requiring large French femoral artery access.
Features
- Specialized closure device for large French 12F-24F femoral artery access sites
- Designed for ease of use during interventional procedures
- Aims to enhance procedural efficiency for interventionalists
- Focuses on secure closure of the femoral artery
- Seeks to optimize patient recovery outcomes